These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 1361777)
21. Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and females. Koh SC; Yuen R; Viegas OA; Chua SE; Ng BL; Sen DK; Ratnam SS Thromb Haemost; 1991 Nov; 66(5):581-5. PubMed ID: 1803623 [TBL] [Abstract][Full Text] [Related]
22. Fibrinolytic activity in peripheral atherosclerosis in the elderly. van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006 [TBL] [Abstract][Full Text] [Related]
23. [Levels of tissue-type plasminogen activator (T-PA), its inhibitor (PAI-1) and fibrinogen in the blood of patients with type 1 and 2 diabetes mellitus]. Kvasnicka J; Skrha J; Perusicová J; Maslowská H; Pochopová L Cas Lek Cesk; 1996 Mar; 135(6):174-7. PubMed ID: 8681360 [TBL] [Abstract][Full Text] [Related]
24. Behaviour of tissue plasminogen activator, plasminogen activator inhibitor 1 and their complex in various disease states. Niwano H; Takahashi H; Tatewaki W; Wada K; Seki Y; Shibata A Blood Coagul Fibrinolysis; 1992 Aug; 3(4):389-93. PubMed ID: 1420814 [TBL] [Abstract][Full Text] [Related]
25. PAI-1, t-PA and circulating hTERT DNA as related to virus infection in liver carcinogenesis. Divella R; Lacalamita R; Tommasi S; Coviello M; Daniele A; Garrisi VM; Abbate I; Simone G; Gadaleta C; Paradiso A; Quaranta M Anticancer Res; 2008; 28(1A):223-8. PubMed ID: 18383849 [TBL] [Abstract][Full Text] [Related]
26. Sex differences in the determinants of fibrinolytic activity. MacCallum PK; Cooper JA; Howarth DJ; Meade TW; Miller GJ Thromb Haemost; 1998 Mar; 79(3):587-90. PubMed ID: 9531046 [TBL] [Abstract][Full Text] [Related]
27. Levels of fibrinolytic activators and inhibitors in plasma after severe trauma. Sørensen JV Blood Coagul Fibrinolysis; 1994 Feb; 5(1):43-9. PubMed ID: 7514044 [TBL] [Abstract][Full Text] [Related]
28. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction. Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044 [TBL] [Abstract][Full Text] [Related]
29. Tissue-type plasminogen activator (tPA) and its inhibitor (PAI-1) in patients treated with continuous ambulatory peritoneal dialysis. Opatrný K; Opatrná S; Vít L; Opatrný K Am J Nephrol; 1998; 18(3):186-92. PubMed ID: 9627033 [TBL] [Abstract][Full Text] [Related]
30. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults. Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281 [TBL] [Abstract][Full Text] [Related]
31. [Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome]. Fukao H; Yamamoto K; Matsuo O Rinsho Byori; 1991 Jul; 39(7):720-6. PubMed ID: 1920864 [TBL] [Abstract][Full Text] [Related]
32. [A study on the circadian variation of tissue-type plasminogen activator and its rapid inhibitor in patients with coronary heart disease]. Chen ZY Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Jun; 21(3):163-4, 188. PubMed ID: 8243232 [TBL] [Abstract][Full Text] [Related]
33. Plasma levels of t-PA and PAI-1 correlate with the formation of experimental post-surgical peritoneal adhesions. Di Filippo C; Falsetto A; De Pascale V; Tufariello E; De Lucia D; Rossi F; D'Amico M; Cennamo A Mediators Inflamm; 2006; 2006(4):13901. PubMed ID: 17047285 [TBL] [Abstract][Full Text] [Related]
34. Coagulation- and fibrinolysis-related antigens in plasma and dialysate of CAPD patients. Goedde M; Sitter T; Schiffl H; Bechtel U; Schramm W; Spannagl M Perit Dial Int; 1997; 17(2):162-6. PubMed ID: 9159837 [TBL] [Abstract][Full Text] [Related]
35. Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering. Haslinger B; Goedde MF; Toet KH; Kooistra T Kidney Int; 2002 Nov; 62(5):1611-9. PubMed ID: 12371961 [TBL] [Abstract][Full Text] [Related]
36. Correlations between plasminogen activator inhibitor-1 and peritoneal transport in pediatric CCPD patients. Lin JJ; Singhal K; Parton L; Cascio C; Patlak CS; Stewart CL Perit Dial Int; 1995; 15(6):246-51. PubMed ID: 7578502 [TBL] [Abstract][Full Text] [Related]
37. D-glucose increases the synthesis of tissue-type plasminogen activator (t-PA) in human peritoneal mesothelial cells. Sitter T; Mandl-Weber S; Wörnle M; Haslinger B; Goedde M; Kooistra T Thromb Haemost; 1999 Sep; 82(3):1171-6. PubMed ID: 10494783 [TBL] [Abstract][Full Text] [Related]
38. [Efffect of plasminogen activator inhibitor-1 and endothelin-1 on the atherosclerosis in the maintenance hemodialysis patients]. Ouyang L; Peng Y; Wu G; Xu X; He Z Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 May; 38(5):458-67. PubMed ID: 23719522 [TBL] [Abstract][Full Text] [Related]
39. Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome. Bergstein JM; Riley M; Bang NU N Engl J Med; 1992 Sep; 327(11):755-9. PubMed ID: 1501651 [TBL] [Abstract][Full Text] [Related]
40. Dynamic changes in plasma tissue plasminogen activator, plasminogen activator inhibitor-1 and beta-thromboglobulin content in ischemic stroke. Zhuang P; Wo D; Xu ZG; Wei W; Mao HM J Clin Neurosci; 2015 Jul; 22(7):1123-7. PubMed ID: 26002716 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]